CoChat

Optimal Glycemic Control, Pre-eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-eclampsia Intervention Trial

Open access
Holmes, Valerie A., Young, Ian S., Patterson, Christopher C., Pearson, Donald W.M., Walker, James D., Maresh, Michael J.A., McCance, David R., for the Diabetes and Pre-eclampsia Intervention Trial Study Group · 2011 · Diabetes Care

The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To assess the relationship between glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes. RESEARCH DESIGN AND METHODS: Pregnancy outcome (pre-eclampsia or gestational hypertension) was assessed prospectively in 749 women from the randomized controlled Diabetes and Pre-eclampsia Intervention Trial (DAPIT). HbA(1c) (A1C) values were available up to 6 months before pregnancy (n = 542), at the first antenatal visit (median 9 weeks) (n = 721), at 26 weeks' gestation (n = 592), and at 34 weeks' gestation (n = 519) and were categorized as optimal (<6.1%: referent), good (6.1-6.9%), moderate (7.0-7.9%), and poor (≥8.0%) glycemic control, respectively. RESULTS: Pre-eclampsia and gestational hypertension developed in 17 and 11% of pregnancies, respectively. Women who developed pre-eclampsia had significantly higher A1C values before and during pregnancy compared with women who did not develop pre-eclampsia (P < 0.05, respectively). In early pregnancy, A1C ≥ 8.0% was associated with a significantly increased risk of pre-eclampsia (odds ratio 3.68 [95% CI 1.17-11.6]) compared with optimal control. At 26 weeks' gestation, A1C values ≥ 6.1% (good: 2.09 [1.03-4.21]; moderate: 3.20 [1.47-7.00]; and poor: 3.81 [1.30-11.1]) and at 34 weeks' gestation A1C values ≥ 7.0% (moderate: 3.27 [1.31-8.20] and poor: 8.01 [2.04-31.5]) significantly increased the risk of pre-eclampsia compared with optimal control. The adjusted odds ratios for pre-eclampsia for each 1% decrement in A1C before pregnancy, at the first antenatal visit, at 26 weeks' gestation, and at 34 weeks' gestation were 0.88 (0.75-1.03), 0.75 (0.64-0.88), 0.57 (0.42-0.78), and 0.47 (0.31-0.70), respectively. Glycemic control was not significantly associated with gestational hypertension. CONCLUSIONS: Women who developed pre-eclampsia had significantly higher A1C values before and during pregnancy. These data suggest that optimal glycemic control both early and throughout pregnancy may reduce the risk of pre-eclampsia in women with type 1 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc11-0244

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 213

Metadata

Authors
Holmes, V. A., Young, I. S., Patterson, C. C., Pearson, D. W. M., Walker, J. D., Maresh, M. J. A., McCance, D. R., & for the Diabetes and Pre-eclampsia Intervention Trial Study Group
Affiliations
  • Queen's University Belfast (GB)
  • Aberdeen Royal Infirmary (GB)
  • St John's Hospital (GB)
  • St Mary's Hospital (GB)
  • Royal Victoria Hospital (GB)
Corresponding author
McCance, David R.
Venue
Diabetes Care
Published
2011-07-16
Volume
34
Issue
8
Pages
1683-1688
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2134759695
Cited by
205
References
26
Citations by year
2026: 7 · 2025: 18 · 2024: 14 · 2023: 21 · 2022: 15 · 2021: 13 · 2020: 16 · 2019: 15 · 2018: 13 · 2017: 16 · 2016: 12 · 2015: 17 · 2014: 9 · 2013: 11 · 2012: 6
FWCI
11.15
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion)
Funders
  • Wellcome Trust (083145/Z/07/Z, 067028, 210183)
  • Queen's University Belfast
  • European Foundation for the Study of Diabetes
  • Queen's University
  • Economic and Social Research Council (ES/G007438/1)
  • Centre for Public Health, Queen's University Belfast
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 1 diabetes in pregnancy, preeclampsia, gestational hypertension, glycemic control, HbA1c, pregnancy outcomes, risk factors, preeclampsia prevention, prenatal care, HbA1c targets, HbA1c thresholds, HbA1c monitoring
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Humans, Pre-Eclampsia, Pregnancy, Hypertension, Pregnancy-Induced, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.